Vasileios Ragos

1.4k total citations
98 papers, 1.1k citations indexed

About

Vasileios Ragos is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Vasileios Ragos has authored 98 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 32 papers in Molecular Biology and 21 papers in Cancer Research. Recurrent topics in Vasileios Ragos's work include Cancer-related Molecular Pathways (11 papers), RNA modifications and cancer (9 papers) and Lung Cancer Treatments and Mutations (8 papers). Vasileios Ragos is often cited by papers focused on Cancer-related Molecular Pathways (11 papers), RNA modifications and cancer (9 papers) and Lung Cancer Treatments and Mutations (8 papers). Vasileios Ragos collaborates with scholars based in Greece, United Kingdom and Germany. Vasileios Ragos's co-authors include Evangelos Tsiambas, Dimitrios Peschos, Nicholas Mastronikolis, Vasileios Papanikolaou, Aristeidis Chrysovergis, Christos Yapijakis, Stylianos Mastronikolis, Antonis Vylliotis, Yannis V. Simos and Eleftherios Vairaktaris and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gene and European Journal of Pharmaceutical Sciences.

In The Last Decade

Vasileios Ragos

93 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vasileios Ragos Greece 19 403 233 220 103 102 98 1.1k
Xiaojuan Xiao China 19 454 1.1× 224 1.0× 120 0.5× 102 1.0× 84 0.8× 55 1.0k
Dong Xue China 20 565 1.4× 209 0.9× 344 1.6× 57 0.6× 170 1.7× 74 1.2k
Juliane Hoffmann Germany 16 559 1.4× 192 0.8× 139 0.6× 98 1.0× 89 0.9× 26 1.1k
Yong Lin China 17 338 0.8× 92 0.4× 191 0.9× 76 0.7× 94 0.9× 42 762
Guodong Zhu China 18 522 1.3× 190 0.8× 189 0.9× 103 1.0× 317 3.1× 67 1.3k
Mallikarjun Patil India 17 447 1.1× 189 0.8× 119 0.5× 56 0.5× 46 0.5× 54 1.0k
Yadong Wang China 18 436 1.1× 207 0.9× 134 0.6× 238 2.3× 83 0.8× 82 1.0k
M. Teresa Agulló-Ortuño Spain 17 435 1.1× 250 1.1× 219 1.0× 43 0.4× 107 1.0× 65 1.1k
Shipra Agrawal United States 23 1.0k 2.5× 133 0.6× 245 1.1× 156 1.5× 74 0.7× 44 1.8k
Suyu Wang China 15 320 0.8× 97 0.4× 212 1.0× 88 0.9× 103 1.0× 42 809

Countries citing papers authored by Vasileios Ragos

Since Specialization
Citations

This map shows the geographic impact of Vasileios Ragos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vasileios Ragos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vasileios Ragos more than expected).

Fields of papers citing papers by Vasileios Ragos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vasileios Ragos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vasileios Ragos. The network helps show where Vasileios Ragos may publish in the future.

Co-authorship network of co-authors of Vasileios Ragos

This figure shows the co-authorship network connecting the top 25 collaborators of Vasileios Ragos. A scholar is included among the top collaborators of Vasileios Ragos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vasileios Ragos. Vasileios Ragos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chrysovergis, Aristeidis, Panagiotis Stathopoulos, Evangelos Tsiambas, et al.. (2024). Clinical Impact of C-myc Oncogenic Diversity on Solid and Lymphoid Malignancies. MAEDICA – a Journal of Clinical Medicine. 19(2). 355–359. 1 indexed citations
2.
Derka, Spyridoula, et al.. (2024). Pleomorphic Adenoma of Minor Salivary Glands: a Rare Case Report. MAEDICA – a Journal of Clinical Medicine. 19(2). 434–438. 1 indexed citations
3.
Papanikolaou, Vasileios, Aristeidis Chrysovergis, Vasileios Ragos, et al.. (2023). Impact of Amplified Oncogenes on Salivary Gland Carcinomas. Cancer Diagnosis & Prognosis. 3(5). 528–532. 1 indexed citations
4.
Mastronikolis, Stylianos, Evangelos Tsiambas, Οlga E. Makri, et al.. (2022). c-FOS Expression Analysis in Pterygia Cell Spot Arrays. In Vivo. 36(5). 2143–2148. 1 indexed citations
5.
Kouzoupis, Anastasios V., Evangelos Tsiambas, George Tsouvelas, et al.. (2022). P53 Suppressor Gene Tissue Microarray-based Protein Expression Analysis in Meningiomas. In Vivo. 36(5). 2205–2210. 1 indexed citations
6.
Chrysovergis, Aristeidis, Nicholas Mastronikolis, Evangelos Tsiambas, et al.. (2022). Impact of Ubiquitination Signaling Pathway Modifications on Oral Carcinoma. Cancer Diagnosis & Prognosis. 2(1). 1–6. 4 indexed citations
7.
Papanikolaou, Vasileios, Aristeidis Chrysovergis, Stylianos Mastronikolis, et al.. (2021). Impact of K-Ras Over-expression in Laryngeal Squamous Cell Carcinoma. In Vivo. 35(3). 1611–1615. 7 indexed citations
8.
Kyrodimos, Efthymios, Aristeidis Chrysovergis, Nicholas Mastronikolis, et al.. (2020). Impact of Chromosome 9 Numerical Imbalances in Oral Squamous Cell Carcinoma: A Pilot Grid-Based Centromere Analysis. Diagnostics. 10(7). 501–501. 2 indexed citations
9.
Papanikolaou, Vasileios, Aristeidis Chrysovergis, Nicholas Mastronikolis, et al.. (2020). Topoisomerase IIa Protein Expression Patterns in Laryngeal Squamous Cell Carcinoma. Anticancer Research. 40(2). 807–811. 3 indexed citations
10.
Giannakopoulos, Xenofon, Hercules Sakkas, Vasileios Ragos, et al.. (2019). Impact of enterococcal urinary tract infections in immunocompromised - neoplastic patients.. PubMed. 24(5). 1768–1775. 19 indexed citations
11.
Alexiou, George Α., Konstantinos I. Tsamis, Evangelia Peponi, et al.. (2019). Combination treatment for glioblastoma with temozolomide, DFMO and radiation.. PubMed. 24(1). 397–404. 18 indexed citations
12.
Tsiambas, Evangelos, et al.. (2019). HER2/Topoisomerase IIa co-amplified breast adenocarcinoma "mirror" cases with different Topoisomerase IIa expression patterns.. PubMed. 22(2). 555–556. 1 indexed citations
13.
Tsiambas, Evangelos, et al.. (2019). Epstein-Barr Virus MicroRNAs in Nasopharyngeal Carcinoma. Pathology & Oncology Research. 26(2). 1347–1348. 1 indexed citations
14.
Karkabounas, Spyridon, Nikolaos G. Papadopoulos, Chryssa Anastasiadou, et al.. (2018). Effects of α -Lipoic Acid, Carnosine, and Thiamine Supplementation in Obese Patients with Type 2 Diabetes Mellitus: A Randomized, Double-Blind Study. Journal of Medicinal Food. 21(12). 1197–1203. 35 indexed citations
15.
Mastronikolis, Nicholas, Evangelos Tsiambas, Andreas Karameris, et al.. (2018). Numerical Imbalances of Chromosome 7 in Oral Squamous Cell Carcinoma. Anticancer Research. 38(4). 2339–2342. 3 indexed citations
16.
Kastanioudakis, Ioannis, et al.. (2017). Anterior Cervical Disc Fusion Does not Affect the Presence of Cervical Vestibular-Evoked Myogenic Potential. The Journal of International Advanced Otology. 13(3). 368–373. 2 indexed citations
17.
Tsiambas, Evangelos, Nicholas Mastronikolis, Stavros N Georgiannos, et al.. (2017). Chromosome 7 Multiplication in EGFR-positive Lung Carcinomas Based on Tissue Microarray Analysis. In Vivo. 31(4). 641–648. 9 indexed citations
18.
Simos, Yannis V., Ioannis I. Verginadis, Anna Batistatou, et al.. (2016). Healing effects of quercetin on full thickness epidermal thermal injury in Wistar rats. International Journal of Phytomedicine. 8(2). 277–281. 4 indexed citations
19.
Simos, Yannis V., Ioannis I. Verginadis, Alexandros Charalabopoulos, et al.. (2016). Correlation of bioelectrical impedance analysis phase angle with changes in oxidative stress on end-stage renal disease patients, before, during, and after dialysis. Renal Failure. 38(5). 738–743. 13 indexed citations
20.
Μέτσιος, Απόστολος, Ioannis I. Verginadis, Yannis V. Simos, et al.. (2012). Cytotoxic and anticancer effects of the triorganotin compound [(C6H5)3Sn(cmbzt)]: An in vitro, ex vivo and in vivo study. European Journal of Pharmaceutical Sciences. 47(2). 490–496. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaojuan Xiao Breakdown of academic impact, for papers by Dong Xue Breakdown of academic impact, for papers by Juliane Hoffmann Breakdown of academic impact, for papers by Yong Lin Breakdown of academic impact, for papers by Guodong Zhu Breakdown of academic impact, for papers by Mallikarjun Patil Breakdown of academic impact, for papers by Yadong Wang Breakdown of academic impact, for papers by M. Teresa Agulló-Ortuño Breakdown of academic impact, for papers by Shipra Agrawal Breakdown of academic impact, for papers by Suyu Wang
Rankless by CCL
2026